Madrona Venture Group, LLC Nautilus Biotechnology, Inc. Transaction History
Madrona Venture Group, LLC
- $93.7 Million
- Q2 2024
A detailed history of Madrona Venture Group, LLC transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Madrona Venture Group, LLC holds 6,020,770 shares of NAUT stock, worth $17.2 Million. This represents 15.03% of its overall portfolio holdings.
Number of Shares
6,020,770
Previous 6,020,770
-0.0%
Holding current value
$17.2 Million
Previous $17.7 Million
20.41%
% of portfolio
15.03%
Previous 15.07%
Shares
2 transactions
Others Institutions Holding NAUT
# of Institutions
81Shares Held
63.8MCall Options Held
2.9KPut Options Held
500-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA16.3MShares$46.4 Million24.08% of portfolio
-
Perceptive Advisors LLC New York, NY12.6MShares$35.9 Million0.85% of portfolio
-
Cercano Management LLC Bellevue, WA7.17MShares$20.4 Million0.45% of portfolio
-
Black Rock Inc. New York, NY3.83MShares$10.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.72MShares$7.76 Million0.0% of portfolio
About Nautilus Biotechnology, Inc.
- Ticker NAUT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,663,000
- Market Cap $355M
- Description
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...